Xcision

Management Team

Professor Cedric Yu
Chief Executive Officer

Professor Cedric Yu, DSc, FAAPM has served as CEO of Xcision since 2011. Dr. Yu is responsible for establishing the company’s strategic priorities, growing the leadership team, providing thought leadership on new product development and fundraising. Dr. Yu has a proven track record as a visionary developer of medical technologies that have transformed the radiotherapy industry. Six of Dr. Yu’s patents are currently licensed by radiotherapy companies, including Varian, Siemens, Elekta and Prowess. Products sold using one such patient for intensity modulated arc therapy, current known as VMAT or Rapid Arc, are used daily in the thousands of radiation oncology departments across the world and have generated billions of dollars in sales of hardware and software systems.

Dr. Yu is the endowed Carl M. Mansfield Professor in Radiation Oncology at the University of Maryland and has a 20-year track record of successful translational research. He has periodically worked with the medical device industry and has prepared FDA 510(k) submissions for five medical devices, all of which were cleared within 120 days. He has published more than 100 peer-reviewed articles in scientific journals, more than 150 published abstracts and seven book chapters and reviews. He holds 21 patents on many inventions in this field.

Peter Maton
Vice President of Engineering

Peter Maton joined Xcision in 2011 as VP of Engineering. In this capacity, he oversees the strategic direction and all technical aspects of development for the GammaPod. Mr. Maton has more than 35 years of management experience in the development of cancer care technology and a successful track record of bringing high quality, safe and reliable products to the market.

Michelle Crawley
Vice President of Operations

Michelle Crawley joined Xcision in 2012 as VP of Operations. In this capacity, she is responsible for developing and implementing the strategy and day-to-day functioning of HR, IT, Logistics, Purchasing, US Manufacturing, Customer and Technical Support, Applications Training, Project Management, Clinical Trials management and Contracts departments.

Ms. Crawley joined the company after over 13 years at Elekta where she served as the Director of North American Operations, Director of Integration and lastly as the VP of Contracts and Sales Support during the company’s largest growth period to date. Prior to her engagement with Elekta, she served on the Space Shuttle program for over 13 years in a variety of technical project management and quality assurance roles.

Rajinder Singh Dhada
Vice President of Global Business Development

Rajinder Singh Dhada joined Xcision in 2016 as VP of Global Business Development. In this capacity, he is responsible for building and managing the company’s network of global distribution partners and directly expanding the company’s cohort of research partners in North America. Mr. Dhada is an experienced multilingual executive with a background strategy development, execution, marketing, sales of solutions to advance cancer care to help improve patient’s quality of life. Mr. Dhada has more than 30 years of business management experience in radiation therapy.

Steve Rubenstein
Vice President of Marketing

Steve Rubenstein joined Xcision in 2016 as Vice President of Marketing. In this capacity, he is responsible for developing and implementing the go-to-market strategy for GammaPod, including the market access programs for securing favorable reimbursement and increasing market awareness and adoption. Mr. Rubenstein joined the company after more than 8 years at Elekta. He is also an experienced consultant, having advised health system and medical technology executives while working in various capacities for five years at The Advisory Board Company, a Washington, DC-based professional services and software firm.

Julianna Hines
Regional Vice President of Sales

Julianna Hines joined Xcision in 2016 as Regional Vice President of Sales. In this capacity, Ms. Hines is responsible for overseeing daily sales activities, designing new and effective sales strategies and building a pipeline of prospective customers by meeting with leaders at potential academic and large community health system to generate market awareness of GammaPod. Ms. Hines has over 30 years of sales and account management in the radiotherapy industry, personally overseeing relationships with hundreds of cancer care institutions in the Eastern US.

Marrine Shen
Financial Controller

Marrine Shen joined Xcision in 2016 as Financial Controller. In this role, she is responsible for the full cycle of Accounting and Finance, which includes establishing financial policies and procedures, generating financial reports and oversight of auditing and tax filing work by external accounting firms. Ms. Shen brings more than 15 years of regulated industry experience, most recently as an Accounting Manager for three years at Merchant Link, a joint venture of J.P. Morgan Chase & Co. and First Data.

Dan Plonski
Vice President of Regulatory Affairs and Quality Assurance

Dan Plonski, RAC joined Xcision in 2017. In his role as Vice President of Regulatory Affairs and Quality Assurance, he is responsible for all aspects of the company’s regulatory strategy and quality assurance requirements. Dan’s activities include planning and coordination of regulatory submissions to support business objectives, communications with regulatory authorities and ongoing implementation, monitoring and improvement of the Quality Management System to assure regulatory compliance.
In joining the Xcision team, Dan brings over 12 years of medical device regulatory affairs and quality assurance experience, having demonstrated a successful track record with industry leading companies including Philips Healthcare and Terumo Medical Systems.

Raising Quality, Improving lives Xcision

Contact Info

A 9176 Red Branch Road, Suite O, Columbia, MD 21045 E info@xcision.com P (443) 681-7500

Quick Links

Follow Us On Social Media

The GammaPod system has received 510(k) clearance from the US Food and Drug Administration.
Please contact Xcision regarding availability in other markets.
Copyright © 2018 Xcision Medical Systems, LLC

Designed | Developed by MedTech Momentum